SLIDE 1
With AI Seppo Kopsala Founder and CEO 19.3.2018
OUR MISSION
”To provide most effective solutions for screening of blinding eye diseases”
With AI Seppo Kopsala Founder and CEO 19.3.2018 OUR MISSION To - - PowerPoint PPT Presentation
With AI Seppo Kopsala Founder and CEO 19.3.2018 OUR MISSION To - - PowerPoint PPT Presentation
With AI Seppo Kopsala Founder and CEO 19.3.2018 OUR MISSION To provide most effective solutions for screening of blinding eye diseases WE ARE OPTOMED HEADQUARTERS Oulu, Finland OPTOMED CHINA Shanghai DIABETES IS THE FASTEST GROWING
SLIDE 2
SLIDE 3
WE ARE OPTOMED
HEADQUARTERS Oulu, Finland OPTOMED CHINA Shanghai
SLIDE 4
DIABETES IS THE FASTEST GROWING REASON FOR BLINDNESS
WORLD
382 M
WORLD
592 M
living with diabetes in 2035
2013 2035
AFR 109.1% MENA 96.2% SEA 70.6% SACA 59.8% WP 46% NAC 37.3% EUR 22.4%
- 35% of diabetics will suffer vision loss
- Screening and early treatment is the only way to
prevent blindness
- 1 billion eye screenings would need to be done every
year
- All countries are currently implementing extensive
screening programs for diabetic retinopathy
- Eye screening market is today 5BUSD
SLIDE 5
TRADITIONAL WAY TO DO SCREENING OF BLINDING EYE DISEASES OUR WAY TO DO SCREENING:
Hand-held cameras connected to automatic diagnosis service
SLIDE 6
SLIDE 7
SLIDE 8
Ophtalmologists Primary care
Available only for few. Over 100 years same methods.
10%
90%
Enabling eye screenings also in primary care
SLIDE 9
R&D and Market entry with first product
Phase 1 (2005-2013) Figure out how to make high quality low cost hand held retinal camera. Phase 2 (2014 -) Commercialize complete product portfolio, and build financially strong company.
KEY GOAL 1: Commericalize ISO 10940 fulfilling hand held retinal
- camera. (Reached 2014)
Phase 3 (2018) Commercialize Smartscope-X that can reach and screen all people in the world.
KEY GOAL 2: Get high quality retinal camera production cost below 1000USD KEY GOAL 3: Provide screening platform with automated diagnosis (AI) capability
POINT A
Optomed established.
POINT B
Affordable eye screenings for all.
Optomed business plan
Smartscope-X Full product family
SLIDE 10
THE FUTURE: EU Horizon 2020 funding for Smartscope X project
AI
+
- EU Horizon 2020 funding total 2MEUR (2017-2019)
- Smartscope X = Our new hand held retinal camera
with automatic diagnosis capability for eye diseases
- Easy to use, effective screening, no experience
needed on grading retinal images.
SLIDE 11
Optomed Oy
www.optomed.com Designed in Finland
Yrttipellontie 1, 90230 Oulu, Finland Tel: +358 20 741 3380 Info@optomed.com